Total returns on $1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | BioPharma Credit PLC (Ordinary Share) | +2.56% |
NAV | BioPharma Credit PLC (Ordinary Share) | +8.92% |
Morningstar's Benchmark | No benchmark | -- |
- STATEMENT RE COHERUS BIOSCIENCES, INC.
- Holding(s) in Company
- Transaction in Own Shares
- NEW INVESTMENT OF UP TO US$400 MILLION
- Total Voting Rights
- NEW INVESTMENT OF UP TO US$100 MILLION
- Net Asset Value(s) and Monthly Factsheet
- Notice of AGM
- Director/PDMR Shareholding
- UPDATES TO THE DISCOUNT CONTROL MECHANISM
More ▼
Key statistics
As of last trade BioPharma Credit PLC (BPCR:LSE) traded at 0.8805, 8.70% above its 52-week low of 0.81, set on Nov 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 1.22bn |
---|---|
Market cap | 1.07bn USD |
Total assets | 1.20bn USD |
Total expense ratio | 1.15% |
High | 0.8805 |
Low | 0.874 |
Previous close | 0.878 |
Average volume | 1.68m |
---|---|
YTD Change | +4.82% |
Beta | 0.2676 |
Diluted NAV (est) | 0.9878 |
Diluted NAV (last pub) | 0.98 |
Premium/Discount | -11.12% |
Net Gearing | 0.00% |
Annual div (ADY) | 0.07 USD |
---|---|
Annual div yield (ADY) | 7.97% |
Div ex-date | Mar 28 2024 |
Div pay-date | Apr 30 2024 |
Data delayed at least 20 minutes, as of May 13 2024 09:45 BST.
More ▼